This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
AbbVie and Sandoz have resolved their patent dispute over AbbVie’s blockbuster i...
A panel of experts who decide the national immunization schedule will meet on Tu...
Antibody-drug conjugates startup Duality Biologics will join the public markets ...
The American Medical Association is urging Optum, a unit of UnitedHealth Group, ...
A union that represents more than 11,000 FDA employees nationwide — the National...
Amgen has enjoyed a monopoly on its blockbuster inflammatory disease drug Enbrel...
On Monday, Pfizer announced it had given up on danuglipron, the company's closel...
The government is fighting in court for a plan to cut spending on overhead resea...
Ironwood Pharmaceuticals is now working with Goldman Sachs in its hunt for compa...
Commerce Secretary Howard Lutnick has indicated more specific timelines as to wh...
Verve Therapeutics is trying to swerve the gene editing industry downturn with n...
Commerce Secretary Howard Lutnick has indicated more specific timelines as to wh...
Pfizer has discontinued its once-daily obesity pill danuglipron after a patient ...
Welcome back to Endpoints Weekly! This week's recap kicks off with Andrew Dunn's...